BioMarin Pharmaceutical Inc.

Q3 2026 13F Holders

Symbol
BMRN
CUSIP
09061G101
Type
Equity
Class
COM
Num filings
18
Total reported value, excl. options
$4.99 M
Manager Report Date Value ($000) Shares Option Type